SCHEMBL28645305

SCHEMBL28645305

CC(C)(C)OC(=O)n1ncc2cc(O)c([N+](=O)[O-])cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.41
ROCK1 Q13464 2/20 0.41
TAOK1 Q7L7X3 2/20 0.41
CLK4 Q9HAZ1 2/20 0.41
EEF2K O00418 1/20 0.41
MAP4K4 O95819 1/20 0.41
CLK2 P49760 1/20 0.41
GSK3B P49841 1/20 0.41
PRKX P51817 1/20 0.41
NEK4 P51957 1/20 0.41
PRKG2 Q13237 1/20 0.41
PKN2 Q16513 1/20 0.41
AURKB Q96GD4 1/20 0.41
PBK Q96KB5 1/20 0.41
SLK Q9H2G2 1/20 0.41
MAP3K20 Q9NYL2 1/20 0.41
CREBBP Q92793 1/20 0.39
CHEK2 O96017 1/20 0.38
PRKACA P17612 1/20 0.38
RPS6KA3 P51812 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28632174 0.88 ROCK2 (0.42) ROCK2ROCK1TAOK1CLK4EEF2K
SCHEMBL16751182 0.83 ROCK2 (0.37) ROCK2ROCK1TAOK1CLK4EEF2K
SCHEMBL16751183 0.83 GPR119 (0.41) ROCK2ROCK1TAOK1CLK4EEF2K
SCHEMBL28627766 0.83 CREBBP (0.37) ROCK2ROCK1TAOK1CLK4EEF2K
SCHEMBL18345074 0.81 EGFR (0.43) ROCK2ROCK1TAOK1CLK4EEF2K
SCHEMBL30516913 0.80 MAPT (0.45) ROCK2ROCK1TAOK1CLK4EEF2K
SCHEMBL3610098 0.80 MAPT (0.45) ROCK2ROCK1TAOK1CLK4EEF2K
SCHEMBL3368910 0.80 ROCK2 (0.47) ROCK2ROCK1TAOK1CLK4EEF2K
SCHEMBL15502414 0.76 POLB (0.41) CREBBPMETELANEALDH1A1LMNA
SCHEMBL29510797 0.75 CREBBP (0.44) CREBBPMETELANEALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109761986-B Tricyclic derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2021-10-08 CN disclosed